US News

Exclusive-U.S. opens criminal probe into alleged lapses at Eli Lilly plant – sources

Published by
Reuters

By Marisa Taylor, Mike Spector and Dan Levine (Reuters) – The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant’s COVID-19 therapy and other drugs, three people familiar with the matter said. The probe represents a significant escalation of the government scrutiny on Lilly. The pharmaceutical company, one of the world’s largest, has been under examination for more than a year by the U.S. Food and Drug Administrati…

Read More

Facebook Comments

Check Also

The FDA's War Against The Truth On Ivermectin

The FDA’s War Against The Truth On Ivermectin ...

Archives